MENU
ESPR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Esperion Therapeutics (ESPR) Ownership - Who owns Esperion Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
495.94M
P/E Ratio
N/A
Total Cash
82.25M
Projected Growth
N/A
Total Debt
266.17M
Revenue
116.33M
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
0.44
Total Debt/Equity
N/A
Revenue/Share
1.13 USD as % of share price
Fundamentals
ESPR
Capitalization
496M
P/E Ratio
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
82.2M
Total Cash/Share
0.44
Total Debt
266M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.13%
Revenue
116M
ROE
N/A
Book Value
-454.99M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
118K
Current Ratio
1.29
Current Revenue Per Employee
134375.00
Dividends Per Share - Security
N/A
EBITDA
-150.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
64.49
Revenue To Assets
-92.23
Shares Held By Institutions
243M
Shares Outstanding - Current
185M
Total Liabilities
661M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-26.756
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3891 Ranchero Drive
Phone
+1 734 887-3903
Employees
240
Web
https://www.esperion.com